GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/Endoscopy/AI in Colonoscopy Withdrawal Time Accuracy: Endoscopy | April 2026
51

AI in Colonoscopy Withdrawal Time Accuracy: Endoscopy | April 2026

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated April 1, 2026

Introduction

Withdrawal time during colonoscopy is a key quality indicator directly linked to adenoma detection and colorectal cancer prevention. However, accurate measurement in routine practice is often inconsistent, especially during procedures involving interventions. This variability limits standardisation and quality benchmarking, prompting interest in artificial intelligence (AI)-based systems to objectively measure withdrawal time.

Problem Statement

Despite the importance of withdrawal time, current measurement relies on manual estimation by endoscopists, which is prone to error and inconsistency, particularly when procedures involve therapeutic interventions. There is a lack of prospective validation of AI systems to determine whether they can reliably and accurately standardise this critical quality metric.

Summary

In this prospective study of 126 patients, AI demonstrated superior accuracy in measuring withdrawal time compared to physicians, with significantly lower error, especially during interventional procedures. In non-interventional cases, AI and physicians performed similarly. Additionally, the AI system generated high-quality procedural image reports with strong endoscopist satisfaction. Overall, this study highlights the potential of AI to improve standardization, enhance quality metrics, and streamline workflow in colonoscopy practice.

Related Q&A

52

GLP-1 Agonists Before Endoscopy (OCULUS Trial): JAMA | April 2026

Introduction Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) agonists have rapidly become integral in the management of type 2 diabetes, obesity, and metabolic diseases due to their...

53

NBI and Acetic Acid Chromoendoscopy in Barrett’s Oesophagus: BMJ Open Gastroenterology | March 2026

Introduction Barrett’s oesophagus represents a well-established precursor to oesophageal adenocarcinoma, with progression from intestinal metaplasia to dysplasia and invasive cancer. Given the poor prognosis of advanced disease, early...

54

Choosing the Right Snare in Gastrointestinal Endoscopy

Introduction Endoscopic resection has evolved rapidly, with increasing emphasis on precision, safety, and complete lesion removal. While advances in techniques such as EMR and ESD have transformed outcomes,...

55

Routine Esophagram After POEM: Clinical Insight | Inspired by Expert Commentary

Introduction Routine esophagram after POEM has long been considered a safety checkpoint to rule out leaks before resuming oral intake. However, with improved procedural techniques and safety, its...

56

Post-Banding Ulcer Bleeding: Alime Pharmaco & Therap | March 2026

Introduction Endoscopic band ligation (EBL) remains the standard of care for managing oesophagal varices, both in acute variceal bleeding and for prophylaxis. However, post-banding ulcer bleeding (PBUB) is...

57

Endoscopic Palliation in Pancreatic Cancer: AMJ, March 2026

This article reviews the endoscopic approach to palliation in pancreatic cancer, emphasising that most patients present with unresectable or metastatic disease, so symptom control becomes central to care....

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer